Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Hartung

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Pharmacoepidemiology and Drug Safety|August 27, 2020
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapySara E Hallvik, Kirbee Johnston, Jonah Geddes, et al.
The Annals of Pharmacotherapy|May 17, 2007
Rates of adverse events of long-acting opioids in a state Medicaid programDaniel M Hartung, Luke Middleton, Dean G Haxby, et al.
Journal of Opioid Management|November 16, 2023
Analgesic methadone prescribing in community health centers among patients with chronic painSteffani R Bailey, Jean P O'Malley, Daniel M Hartung, et al.
Pain Medicine (Malden, Mass.)|April 15, 2020
Evaluation of an Interdisciplinary Controlled Substance Review Committee on Opioid Prescribing in a Community Health CenterHolly C Bourgeois, Rachel C Proteau, Cassandra V Vielma, et al.
Journal of Managed Care Pharmacy : JMCP|August 24, 2006
Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid programAnn M Hamer, Daniel M Hartung, Dean G Haxby, et al.
JAMA|February 13, 2019
Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018Daniel M Hartung, Kirbee Johnston, Jonah Geddes, et al.
Neurology. Clinical Practice|February 19, 2026
Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021Daniel M Hartung, Nico Gabriel, Walid F Gellad, et al.
Clinical Therapeutics|November 9, 2004
Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid populationDaniel M Hartung, Daniel R Touchette, Kathy L Ketchum, et al.
JAMA Network Open|January 16, 2019
Industry Payments to Physician Specialists Who Prescribe Repository CorticotropinDaniel M Hartung, Kirbee Johnston, David M Cohen, et al.
Journal of Comparative Effectiveness Research|October 30, 2012
Role of practice-based research networks in comparative effectiveness researchDaniel M Hartung, Jeanne-Marie Guise, Lyle J Fagnan, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Pharmacoepidemiology and Drug Safety|August 27, 2020
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapySara E Hallvik, Kirbee Johnston, Jonah Geddes, et al.
The Annals of Pharmacotherapy|May 17, 2007
Rates of adverse events of long-acting opioids in a state Medicaid programDaniel M Hartung, Luke Middleton, Dean G Haxby, et al.
Journal of Opioid Management|November 16, 2023
Analgesic methadone prescribing in community health centers among patients with chronic painSteffani R Bailey, Jean P O'Malley, Daniel M Hartung, et al.
Pain Medicine (Malden, Mass.)|April 15, 2020
Evaluation of an Interdisciplinary Controlled Substance Review Committee on Opioid Prescribing in a Community Health CenterHolly C Bourgeois, Rachel C Proteau, Cassandra V Vielma, et al.
Journal of Managed Care Pharmacy : JMCP|August 24, 2006
Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRI antidepressants in a state Medicaid programAnn M Hamer, Daniel M Hartung, Dean G Haxby, et al.
JAMA|February 13, 2019
Buprenorphine Coverage in the Medicare Part D Program for 2007 to 2018Daniel M Hartung, Kirbee Johnston, Jonah Geddes, et al.
Neurology. Clinical Practice|February 19, 2026
Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021Daniel M Hartung, Nico Gabriel, Walid F Gellad, et al.
Clinical Therapeutics|November 9, 2004
Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid populationDaniel M Hartung, Daniel R Touchette, Kathy L Ketchum, et al.
JAMA Network Open|January 16, 2019
Industry Payments to Physician Specialists Who Prescribe Repository CorticotropinDaniel M Hartung, Kirbee Johnston, David M Cohen, et al.
Journal of Comparative Effectiveness Research|October 30, 2012
Role of practice-based research networks in comparative effectiveness researchDaniel M Hartung, Jeanne-Marie Guise, Lyle J Fagnan, et al.
Pageof 11